New York, NY -- (SBWIRE) -- 01/08/2014 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: BG Medicine, Inc (NASDAQ:BGMD), Genco Shipping & Trading Limited (NYSE:GNK), Vical Incorporated (NASDAQ:VICL), Atlantic Power Corp (NYSE:AT)
BG Medicine, Inc (NASDAQ:BGMD) showed a volume of 1.75 million shares by the end of last trade whereas the average volume of the stock remained 2.81 million shares. The stock opened the session at $1.41 but then moved to $1.27. At that price, the stock showed a negative performance of -9.29%. BG Medicine, Inc. (BG Medicine) is a life sciences company focused on the discovery, development and commercialization of cardiovascular diagnostics to addresses unmet medical needs. The Company focuses on blood-based tests. Its lead product candidate in development is CardioSCORE, which is a multi-analyte biomarker-based blood test for atherothrombotic cardiovascular disease, commonly known as vulnerable plaque. In March 2011, the Company entered into a supply agreement with Health Diagnostic Laboratory, Inc. (HDL), pursuant to which HDL agreed to purchase manual galectin-3 test kits from the Company and to offer galectin-3 testing services to physicians in the United States.
Will BGMD Get Buyers Even After The Recent Rally? Find Out Here
Genco Shipping & Trading Limited (NYSE:GNK) opened the session at $2.41 and closed the session at $2.59. The stock showed a negative performance of 8.37% in previous trading session. Traded with volume of 1.74 million shares in the prior session and the average volume of the stock remained 2.02 million shares. Genco Shipping & Trading Limited (GS&T) transports iron ore, coal, grain, steel products and other drybulk cargoes along worldwide shipping routes through the ownership and operation of drybulk carrier vessels. As of December 31, 2012, GS&T’s fleet consisted of 53 drybulk carriers, including nine capesize, eight panamax, 17 supramax, six handymax and 13 handysize drybulk carriers, with an aggregate carrying capacity of approximately 3,810,000 deadweight tonnages.
For How Long GNK will fight for Profitability? Read This Trend Analysis report
Vical Incorporated (NASDAQ:VICL) opened the session at $1.27 and closed the session at $1.31. The stock showed a positive performance 3.97% in previous trading session. Traded with volume of 1.73 million shares in the prior session and the average volume of the stock remained 1.27 million shares. The beta of the stock remained 1.51. Vical Incorporated researches and develops biopharmaceutical products based on its deoxyribonucleic acid (DNA) delivery technologies for the prevention and treatment of serious or life-threatening diseases. The Company has three active independent clinical and preclinical development programs in the areas of infectious disease and cancer, including a fully enrolled Phase III clinical trial using its Allovectin immunotherapeutic in patients with metastatic melanoma; a completed preclinical program, with an allowed investigational new drug application,
Why Should Investors Buy VICL After The Recent Gain? Just Go Here and Find Out
Atlantic Power Corp (NYSE:AT) the stock advanced 6.53% and finished the session at $3.59. Traded with volume of 1.70 million shares in the prior session and the average volume of the stock remained 1.42 million shares. The beta of the stock remained 0.41. Atlantic Power Corporation (Atlantic Power) owns and operates a fleet of power generation and infrastructure assets in the United States and Canada. The Company’s power generation projects sell electricity to utilities and industrial customers under long-term power purchase agreements. During the year ended December 31, 2011, its power generation projects in operation had an aggregate gross electric generation capacity of approximately 3,397 megawatts in which its ownership interest was approximately 2,140 megawatts. The Company operates in five segments: Northeast, Southeast, Northwest,
Will AT Continue To Move Higher? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)